![Profile Image](https://pbs.twimg.com/profile_images/1370100950086615041/CDHmaPbH_normal.jpg)
Ro Khanna @RoKhanna
The CBO in Footnote 11 cites a Pfizer funded study to claim lowering drug prices hurts innovation. No analysis on how channeling Medicare savings to increased NIH funding would lead to new drug development. Sloppy thinking which wouldn’t pass Econ 101! https://t.co/gFZKKYlnNK — PolitiTweet.org